Literature DB >> 10218631

Progressive supranuclear palsy with dementia: cortical pathology.

E H Bigio1, D F Brown, C L White.   

Abstract

Patients with progressive supranuclear palsy (PSP) often develop dementia, and cortical pathology has been documented in PSP. However, there are no reports correlating dementia in PSP with cortical pathology. We hypothesized that cases of PSP presenting with cognitive impairment would have more severe cortical tau pathology than those without. We compared 7 cases of PSP presenting with cognitive deficits (group 1) with 4 cases of PSP that did not (group 2). The subcortical tau pathology was almost identical in both groups. The cortical tau pathology was strikingly different in group 1, in which it was on average moderate, compared with group 2, in which it was minimal. The accumulation of cortical neuronoglial tau in PSP cases with dementia suggests that neurofibrillary pathology is central to the cause of dementia in PSP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218631     DOI: 10.1097/00005072-199904000-00006

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  19 in total

1.  The relationship between clinical and pathological variables in Richardson's syndrome.

Authors:  Emma C Schofield; John R Hodges; Thomas H Bak; John H Xuereb; Glenda M Halliday
Journal:  J Neurol       Date:  2011-08-12       Impact factor: 4.849

2.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Authors:  K Spittaels; C Van den Haute; J Van Dorpe; K Bruynseels; K Vandezande; I Laenen; H Geerts; M Mercken; R Sciot; A Van Lommel; R Loos; F Van Leuven
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia.

Authors:  Christopher Kobylecki; Matthew Jones; Jennifer C Thompson; Anna M Richardson; David Neary; David M A Mann; Julie S Snowden; Alexander Gerhard
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

Review 4.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 5.  Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).

Authors:  Dennis W Dickson; Naomi Kouri; Melissa E Murray; Keith A Josephs
Journal:  J Mol Neurosci       Date:  2011-07-01       Impact factor: 3.444

Review 6.  Progressive supranuclear palsy.

Authors:  K Tawana; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

Review 7.  Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology.

Authors:  Jennifer L Whitwell; Keith A Josephs
Journal:  Nat Rev Neurol       Date:  2012-01-31       Impact factor: 42.937

8.  MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects.

Authors:  Dominic C Paviour; Shona L Price; Andrew J Lees; Nick C Fox
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

9.  Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases.

Authors:  R A Armstrong; P L Lantos; N J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2007-08-07       Impact factor: 3.575

Review 10.  Neuropathology of non-Alzheimer degenerative disorders.

Authors:  Dennis W Dickson
Journal:  Int J Clin Exp Pathol       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.